SCOPUS 정보 검색 플랫폼

Neurology: Neuroimmunology and NeuroInflammation

Volumn 1, Issue 4, 2014, Pages

Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children

(4) Longoni, Giulia a,b,c,d Banwell, Brenda e Filippi, Massimo a,b,c Yeh, E Ann a,d

a Institute of Experimental Neurology (Italy)

b Division of Neuroscience (Italy)

c VITA SALUTE SAN RAFFAELE UNIVERSITY (Italy)

d HOSPITAL FOR SICK CHILDREN (Canada)

e UNIVERSITY OF PENNSYLVANIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DISEASE CONTROL; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRUG TOLERABILITY; EXPANDED DISABILITY STATUS SCALE; FACE RASH; FEMALE; FOLLOW UP; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; MALE; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; URTICARIA;

EID: 84944227542 PISSN: None EISSN: 23327812 Source Type: Journal
DOI: 10.1212/NXI.0000000000000046 Document Type: Article

Times cited : (42)

References (10)

1
- 34547791832
- The spectrum of neuromyelitis optica
- Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-815.
- (2007) Lancet Neurol , vol.6 , pp. 805-815
- Wingerchuk, D.M.¹ Lennon, V.A.² Lucchinetti, C.F.³ Pittock, S.J.⁴ Weinshenker, B.G.⁵

2
- 84865262140
- Treatment of neuromyelitis optica: Review and recommendations
- Kimbrough DJ, Fujihara K, Jacob A, et al. Treatment of neuromyelitis optica: review and recommendations. Mult Scler Relat Disord 2012;1:180-187.
- (2012) Mult Scler Relat Disord , vol.1 , pp. 180-187
- Kimbrough, D.J.¹ Fujihara, K.² Jacob, A.³

3
- 39749113222
- Neuromyelitis optica-igg in childhood inflammatory demyelinating CNS disorders
- Banwell B, Tenembaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344-352.
- (2008) Neurology , vol.70 , pp. 344-352
- Banwell, B.¹ Tenembaum, S.² Lennon, V.A.³

4
- 16844366404
- An open label study of the effects of rituximab in neuromyelitis optica
- Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005;64: 1270-1272.
- (2005) Neurology , vol.64 , pp. 1270-1272
- Cree, B.A.¹ Lamb, S.² Morgan, K.³ Chen, A.⁴ Waubant, E.⁵ Genain, C.⁶

5
- 79954613355
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- Pellkofer HL, Krumbholz M, Berthele A, et al. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology 2011;76: 1310-1315.
- (2011) Neurology , vol.76 , pp. 1310-1315
- Pellkofer, H.L.¹ Krumbholz, M.² Berthele, A.³

6
- 84883820098
- A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder
- Kim SH, Huh SY, Lee SJ, Joung A, Kim HJ. A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder. JAMA Neurol 2013;70: 1110-1117.
- (2013) JAMA Neurol , vol.70 , pp. 1110-1117
- Kim, S.H.¹ Huh, S.Y.² Lee, S.J.³ Joung, A.⁴ Kim, H.J.⁵

7
- 47549088163
- CNS aquaporin-4 autoimmunity in children
- McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71: 93-100.
- (2008) Neurology , vol.71 , pp. 93-100
- McKeon, A.¹ Lennon, V.A.² Lotze, T.³

8
- 58149144305
- Spectrum of pediatric neuromyelitis optica
- Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JV. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008;122:e1039-e1047.
- (2008) Pediatrics , vol.122 , pp. e1039-e1047
- Lotze, T.E.¹ Northrop, J.L.² Hutton, G.J.³ Ross, B.⁴ Schiffman, J.S.⁵ Hunter, J.V.⁶

9
- 79551623134
- Efficacy and safety of rituximab in pediatric neuromyelitis optica
- Mahmood NA, Silver K, Onel K, Ko M, Javed A. Efficacy and safety of rituximab in pediatric neuromyelitis optica. J Child Neurol 2011;26:244-247.
- (2011) J Child Neurol , vol.26 , pp. 244-247
- Mahmood, N.A.¹ Silver, K.² Onel, K.³ Ko, M.⁴ Javed, A.⁵

10
- 84902500189
- Rituximab use in pediatric central demyelinating disease
- Beres SJ, Graves J, Waubant E. Rituximab use in pediatric central demyelinating disease. Pediatr Neurol 2014;51: 114-118.
- (2014) Pediatr Neurol , vol.51 , pp. 114-118
- Beres, S.J.¹ Graves, J.² Waubant, E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.